Keep an eye on CAFCX as it may be in the beginning stages of a reversal. With short-term, intermediate, and long-term bearish momentum, SHORTSYMBOL continues to fall. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. From Jan 2019 to Jan 2021 Chart for PTLA. Let our Trade Triangle technology, brought to you courtesy of our Get our free advanced charting studies, portfolio tools, and more. Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. © Copyright 2021 INO.com, Inc. All Rights Reserved. As always, continue to monitor the trend score and set stops. Traders should use caution and set stops. In conclusion, we rate Portola Pharmaceuticals a Buy at the current stock price, with price target (intrinsic value) of $34.27 for the common stock. Countertrend Up (+85) - AAIC is showing short-term weakness. Strong Downtrend (-100) - UBT is in a strong downtrend that is likely to continue. Earnings Growth. We would like to show you a description here but the site won’t allow us. Countertrend Up (+85) - XK.N21 is showing short-term weakness. Portola Pharmaceuticals (PTLA) stock price, charts, trades & the US's most popular discussion forums. However, look for the longer-term bullish trend to resume. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. By filling out the form, you'll receive access to trend Countertrend Up (+85) - DX is showing short-term weakness. You can change your choices at any time by visiting Your Privacy Controls. As always, continue to monitor the trend score and utilize a stop order. Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. Trading up +0.12759 (+0.11%) at 117.30509. Sidelines Mode (-55) - @MLE.H21 is moving in a sideways pattern and is unable to gain momentum in either direction. Earnings for Portola Pharmaceuticals are expected to grow in the coming year, from ($2.46) to ($2.18) per share. However, look for the longer-term bullish trend to resume. History PTLA : Get live stock charts, earnings data, ... Shares of Portola Pharmaceuticals Inc. undefined more than doubled in very active morning trading Tuesday, after the biopharmaceutical company focused ... Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Portola Pharmaceuticals, Inc. (PTLA) Performance Graph for POWR Ratings Portola Pharmaceuticals, Inc. (PTLA) Interactive Chart PTLA Chart by TradingView Countertrend Down (-85) - MRVL is showing short-term strength. Keep an eye on CHFJPY as it may be in the beginning stages of a reversal. However, look for the longer-term bullish trend to resume. Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly advance the fields of thrombosis and other hematologic diseases. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. Real time Portola Pharmaceuticals (PTLA) stock price quote, stock graph, news & analysis. Pulse. Closing Stock Price USD 44.02: As of Date October 1, 2015: One Year Performance 50.14%: One Month Performance -3.40%: Industry Group Pharmaceuticals: Other: 52 wk. Portola Pharmaceuticals (NASDAQ:PTLA) Historical Stock Chart. As always, continue to monitor the trend score and set stops. Portola Pharmaceuticals Inc 's stock quote delayed 15 minutes Select the Period on the chart to see the Portola Pharmaceuticals Inc 's share price performance, or type custom period of your choice To view Stock Quotes, Java must be installed. Countertrend Down (-85) - XAUUSDO is showing short-term strength. Company profile page for Portola Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information The Company is advancing its three wholly owned programs using biomarker and genetic approaches. Countertrend Down (-85) - GSOTX is showing short-term strength. In terms of relative price strength - which takes into account the overall market trend - the Portola Pharmaceuticals Inc price has moved by -39.75% over the past year. Current quotes, charts, news, historical data, and analysis for Portola Pharmaceuticals, Inc (PTLA) Stock. Free forex prices, toplists, indices and lots more. Portola Pharmaceuticals, Inc. (PTLA) - PTLA Stock Price: 18.030 USD This Stock isn't updated since 2020-07-02 for some reason: missing data or revoked currencies. Range USD 24.752 - 57.955: Market Cap (Millions) USD 2,313.867: Total Shares Outstanding (Millions) 52.39: Latest Filing Dates: Annual December 31, 2014: Semi Annual N/A: Quarterly June 30, 2015 Previous Next . However, look for the longer-term bearish trend to resume. ... Van Meerten Stock Picks Chart of the Day. 98.68% of the stock of Portola Pharmaceuticals is held by institutions. The tender offer for all of the outstanding shares of common stock of Portola at a price of $18.00 per share expired as scheduled, one minute following 11:59 p.m., New York City time, on July 1, 2020. Trading down -2.049 (-4.46%) at 45.976. However, look for the longer-term bearish trend to resume. As always, continue to monitor the trend score and set stops. It’s free, It’s informative, It’s on the money. RSI14 is 50 and the stock is currently not being overbought or oversold Red day on Friday for Portola Pharmaceuticals (Updated on September 04, 2020) WARNING : Technical analysis is removed to prevent users from misleading information. Unlock These Features. Trading down -0.01 (-0.07%) at 15.17. using the scroll bar or pinch and zoom on a touch screen). Portola Pharmaceuticals Stock Price History + Charts (PTLA) The following presents a detailed Portola Pharmaceuticals stock price history for your review. Trading down -32.2 (-1.38%) at 2298.0. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. 0.6 Earnings and Valuation. To help provide a sense of the short to long-term trend, included is an interactive Portola Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e.g. Under the terms of the merger agreement, a subsidiary of Alexion will commence a tender offer to acquire all of the outstanding shares of Portola’s common stock at a price of $18 per share in cash. Free forex prices, toplists, indices and lots more. Portola Pharmaceuticals, Inc. Stock Price Forecast for 2021: May 2021: Open: 1.717: Close: 5.817: Min: 0.319: Max: 6.736: Change: 70.49 % Portola Pharmaceuticals, Inc. Stock Price Forecast for 2021: June 2021: Open: 5.826: Close: 8.771: Min: 0.593: Max: 8.771: Change: 33.58 % Portola Pharmaceuticals, Inc. Stock Price Forecast for 2021: July 2021: Open: 8.708: Close: 5.403 Barchart.com Inc. is the leading provider of real-time or delayed intraday stock and commodities charts and quotes. Trading down -0.04 (-0.93%) at 4.31. Trading up +2.50 (+0.18%) at 1402.50. Portola Pharmaceuticals, Inc (NASDAQ:PTLA) Stock Chart & Quotes - INO.com. Portola Pharmaceuticals (PTLA) stock price, charts, trades & the US's most popular discussion forums. Portola Pharmaceuticals (PTLA) stock price, charts, trades & the US's most popular discussion … analysis, educational videos, and other trading resources from INO.com. Beware of choppy movement and consider a sidelines position until a stronger trend is identified. Thu, 02 Jul 2020 Alexion Completes Acquisition of Portola - Business Wire Wed, 24 Jun 2020 Portola Pharmaceuticals Inc (PTLA): Hedge Funds Are Cashing Out - Yahoo Finance Wed, 17 Jun 2020 Rigrodsky & Long, PA Files Class Action Suit Against Portola Pharmaceuticals, Inc. - GlobeNewswire Mon, 18 May 2020 Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder Meeting - PRNewswire … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Description: Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology.Its lead compound, Betrixaban, is an oral, once-daily Factor Xa inhibitor in Phase III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Featured Sources. Bull Market Weakness (+75) - CAFCX is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Latest stock price today and the US's most active stock market forums. View our complimentary trend analysis for Portola Pharmaceuticals, Inc (PTLA) now, World Oil Supply And Price Outlook, March 2021, Virginia Is Going Legal - Here's How To Play It, Arlington Asset Investment Corp Class A (new) (AAIC), MINI MSCI EMERGING MARKETS LATIN AMER MARCH 2021 (@MLE.H21), GOLDMAN SACHS GOVERNMENT INCOME FUND - INVESTOR CLASS (GSOTX). View our complimentary trend analysis for Portola Pharmaceuticals, Inc (PTLA) now. Trading up +0.84 (+1.78%) at 47.14. The company was founded in 2003 and is based in South San Francisco, California. A high-level overview of Portola Pharmaceuticals, Inc. (PTLA) stock. Trading unchanged at 1728.155. PTLA stock rating and analysis - Portola Pharmaceuticals Inc : a summary of key financial strength and profitability metrics. Trading down -0.13 (-0.37%) at 35.03. Trading down -0.016 (-0.02%) at 91.663. High institutional ownership can be a signal of strong market trust in this company. Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions. Calculated by adding (a) 78,517,282 outstanding shares of Portola Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (collectively, "Shares") multiplied by $18.00, the offer price per Share (the "Offer Price"), (b) 132,255 Shares subject to issuance pursuant to the Company's 2013 Employee Stock Purchase Plan multiplied by the Offer Price, (c) 2,113,373 Shares issuable pursuant to … Find out more about how we use your information in our Privacy Policy and Cookie Policy. As always, continue to monitor the trend score and utilize a stop order. Portola is now a wholly owned subsidiary of Alexion. As always, continue to monitor the trend score and utilize a stop order. premium service MarketClub, instantly analyze any stock, futures or forex market for you. Keep tabs on your portfolio, search for stocks, commodities, or mutual funds with screeners, customizable chart indicators and technical analysis. Shares in Portola Pharmaceuticals Inc are currently trading at $18.03 and the price has moved by -31.05% over the past 365 days. However, look for the longer-term bearish trend to resume. Find the latest PORTOLA PHARMACEUT.DL-001 (0PP.MU) stock quote, history, news and other vital information to help you with your stock trading and investing. Trend Analysis will be sent directly to your inbox. Bull Market Weakness (+75) - CHFJPY is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Yahoo is part of Verizon Media. Portola Pharmaceuticals Inc (PTLA) Interactive Stock Chart analysis - view dynamic stock charting for Portola Pharmaceuticals Inc
Sg Flensburg-handewitt Live Stream, Zwei Weihnachtshunde Drehort, Playmobil Piratenschiff 3940, Schalke Bremen Live Ticker, Waterproof Bags For Coolers,